| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cartesian Therapeutics, Inc. (RNAC) has 13 insiders with recent SEC Form 4 filings, including 18 buys and 0 sells. RNAC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.65M | $72.80M | - | |
| 10% | 511.6K | $4.31M | - | |
| CEO | 323.5K | $2.72M | - | |
| CFO | 121.2K | $1.02M | - | |
| Other | 94.2K | $793.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 27, 2016 | Tas Partners, LLC | Director | Buy | 710,000 | $14.00 | $9,940,000.00 | +134.7% | |
| Jun 27, 2016 | Nashat Amir | Director, 10% Owner | Buy | 150,000 | $14.00 | $2,100,000.00 | +8.6% | |
| Jun 27, 2016 | Orbimed Advisors LLC67 | Director, 10% Owner | Buy | 550,000 | $14.00 | $7,700,000.00 | +42.5% | |
| Jun 27, 2016 | Gordon Carl L74 | Director, 10% Owner | Buy | 550,000 | $14.00 | $7,700,000.00 | +42.5% | |
| Jun 27, 2016 | Orbimed Advisors LLC67 | Director, 10% Owner | Buy | 550,000 | $14.00 | $7,700,000.00 | +42.5% | |
| Jun 27, 2016 | Nanodimension Management Ltd | 10% Owner | Buy | 385,000 | $14.00 | $5,390,000.00 | +58.2% | |
| Jun 27, 2016 | Polaris Venture Management Co. V, L.l.c. | 10% Owner | Buy | 150,000 | $14.00 | $2,100,000.00 | +8.6% | |
| Jun 27, 2016 | Rusnano | 10% Owner | Buy | 107,143 | $14.00 | $1,500,002.00 | +214.9% | |
| Jun 27, 2016 | Osage University Partners Ii, L.P. | 10% Owner | Buy | 350,000 | $14.00 | $4,900,000.00 | +68.3% |